
Annual Galleri Screening Reduced Stage IV Cancer Diagnoses but Missed Primary Endpoint in First Randomized MCED Trial
<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxNb2c5NEtXaVd5REVuUDNxWGl4QVF1ejdJREkxM0ROWFJmUjB2d1M2TkxqbF9CQTZDdXVJbDJMOVZRQjBfUnNZQ1F2MEpaajFwY29yRi04ZjVMN3Y5OUFlNEM1ZUxPSkdfdFB5b0dIS25jdDE3TWNmT0x4WkhDcFhSc1lncmxpNU1fVDdtWU16RENXc3o0SFl4WmwtZkF4c0xBQlBrVVh6Wnl6MDdITnNXUzFuWE9iS29DMGJUWWVhNmRGWEpMbGo4SUhsZ0lXbjBLdW9sdjNQZEM2ekNxU05KYWkxSEY4Umg2Y0E?oc=5" target="_blank">Annual Galleri Screening Reduced Stage IV Cancer Diagnoses but Missed Primary Endpoint in First Randomized MCED Trial</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
